W. Paul Duprex

11.9k total citations · 3 hit papers
120 papers, 6.2k citations indexed

About

W. Paul Duprex is a scholar working on Epidemiology, Infectious Diseases and Genetics. According to data from OpenAlex, W. Paul Duprex has authored 120 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Epidemiology, 53 papers in Infectious Diseases and 29 papers in Genetics. Recurrent topics in W. Paul Duprex's work include Virology and Viral Diseases (88 papers), Respiratory viral infections research (53 papers) and Virus-based gene therapy research (27 papers). W. Paul Duprex is often cited by papers focused on Virology and Viral Diseases (88 papers), Respiratory viral infections research (53 papers) and Virus-based gene therapy research (27 papers). W. Paul Duprex collaborates with scholars based in United States, United Kingdom and Netherlands. W. Paul Duprex's co-authors include Rik L. de Swart, B. K. Rima, Stephen McQuaid, Linda J. Rennick, Rory D. de Vries, Martin Ludlow, Bertus K. Rima, Sham Nambulli, Albert D. M. E. Osterhaus and Geert van Amerongen and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

W. Paul Duprex

118 papers receiving 6.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape

2021 332 citations Kevin R. McCarthy, Linda J. Rennick et al. Science profile →
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2

2020 265 citations Yufei Xiang, Sham Nambulli et al. Science profile →
ICTV Virus Taxonomy Profile: Paramyxoviridae

2019 208 citations B. K. Rima, Anne Balkema‐Buschmann et al. Journal of General Virology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. Paul Duprex United States	44	3.5k	2.6k	1.5k	982	931	120	6.2k
Geert van Amerongen Netherlands	50	5.8k 1.6×	4.8k 1.9×	2.0k 1.3×	1.1k 1.1×	761 0.8×	160	9.4k
B. K. Rima United Kingdom	43	3.8k 1.1×	1.6k 0.6×	725 0.5×	666 0.7×	1.1k 1.2×	127	5.0k
Alexander Bukreyev United States	46	3.2k 0.9×	4.0k 1.5×	1.0k 0.7×	871 0.9×	505 0.5×	140	6.1k
Davide Corti United States	50	2.3k 0.7×	5.0k 1.9×	2.0k 1.3×	1.9k 1.9×	637 0.7×	114	8.6k
Paul Pumpens Latvia	36	2.9k 0.8×	2.1k 0.8×	1.7k 1.2×	2.2k 2.3×	695 0.7×	81	7.3k
Ursula J. Buchholz United States	39	4.1k 1.1×	3.3k 1.3×	866 0.6×	500 0.5×	519 0.6×	96	5.6k
Adam S. Lauring United States	36	1.3k 0.4×	2.6k 1.0×	524 0.4×	1.4k 1.5×	823 0.9×	98	5.1k
Rory D. de Vries Netherlands	36	2.3k 0.6×	1.9k 0.7×	1.2k 0.8×	640 0.7×	376 0.4×	116	4.1k
Veronika von Messling Germany	37	3.1k 0.9×	1.2k 0.5×	902 0.6×	628 0.6×	1.4k 1.5×	94	4.3k
J.C. de Jong Netherlands	36	6.6k 1.9×	4.0k 1.5×	1.2k 0.8×	1.5k 1.5×	1.5k 1.6×	104	8.9k

Countries citing papers authored by W. Paul Duprex

Since Specialization

Citations

This map shows the geographic impact of W. Paul Duprex's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Paul Duprex with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Paul Duprex more than expected).

Fields of papers citing papers by W. Paul Duprex

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Paul Duprex. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Paul Duprex. The network helps show where W. Paul Duprex may publish in the future.

Co-authorship network of co-authors of W. Paul Duprex

This figure shows the co-authorship network connecting the top 25 collaborators of W. Paul Duprex. A scholar is included among the top collaborators of W. Paul Duprex based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Paul Duprex. W. Paul Duprex is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sage, Valerie Le, Aoife K. O’Connell, Kevin R. McCarthy, et al.. (2025). Influenza A(H5N1) Immune Response among Ferrets with Influenza A(H1N1)pdm09 Immunity. Emerging infectious diseases. 31(3). 477–487. 11 indexed citations

Nambulli, Sham, Nicolas Escriou, Linda J. Rennick, et al.. (2024). A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease. Journal of Virology. 98(5). e0176223–e0176223. 1 indexed citations

Schmitz, Katharina S., Linda J. Rennick, Natasha L. Tilston‐Lunel, et al.. (2024). Rational attenuation of canine distemper virus (CDV) to develop a morbillivirus animal model that mimics measles in humans. Journal of Virology. 98(3). e0185023–e0185023.

Schmitz, Katharina S., Geert van Amerongen, Laurine C. Rijsbergen, et al.. (2023). Inoculation of raccoons with a wild-type-based recombinant canine distemper virus results in viremia, lymphopenia, fever, and widespread histological lesions. mSphere. 8(4). e0014423–e0014423. 3 indexed citations

Laksono, Brigitta M., Anouskha D. Comvalius, Katharina S. Schmitz, et al.. (2023). Infection of ferrets with wild type-based recombinant canine distemper virus overwhelms the immune system and causes fatal systemic disease. mSphere. 8(4). 4 indexed citations

Guseman, Alex J., Linda J. Rennick, Sham Nambulli, et al.. (2023). Targeting spike glycans to inhibit SARS-CoV2 viral entry. Proceedings of the National Academy of Sciences. 120(38). e2301518120–e2301518120. 5 indexed citations

Norris, Michael, William B. Kiosses, Jieyun Yin, et al.. (2022). Measles and Nipah virus assembly: Specific lipid binding drives matrix polymerization. Science Advances. 8(29). eabn1440–eabn1440. 22 indexed citations

Tilston‐Lunel, Natasha L., Stephen R. Welch, Sham Nambulli, et al.. (2021). Sustained Replication of Synthetic Canine Distemper Virus Defective Genomes In Vitro and In Vivo. mSphere. 6(5). e0053721–e0053721. 11 indexed citations

McCarthy, Kevin R., Linda J. Rennick, Sham Nambulli, et al.. (2021). Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. Science. 371(6534). 1139–1142. 332 indexed citations breakdown →

10.

Klimstra, William B., Natasha L. Tilston‐Lunel, Sham Nambulli, et al.. (2020). SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients. Journal of General Virology. 101(11). 1156–1169. 86 indexed citations

11.

Xiang, Yufei, Sham Nambulli, Zhengyun Xiao, et al.. (2020). Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2. Science. 370(6523). 1479–1484. 265 indexed citations breakdown →

12.

Welch, Stephen R., Natasha L. Tilston‐Lunel, Michael K. Lo, et al.. (2019). Inhibition of Nipah Virus by Defective Interfering Particles. The Journal of Infectious Diseases. 221(Supplement_4). S460–S470. 29 indexed citations

13.

Rima, B. K., Anne Balkema‐Buschmann, William G. Dundon, et al.. (2019). ICTV Virus Taxonomy Profile: Paramyxoviridae. Journal of General Virology. 100(12). 1593–1594. 208 indexed citations breakdown →

14.

MacLoughlin, Ronan, Geert van Amerongen, James B. Fink, et al.. (2015). Optimization and Dose Estimation of Aerosol Delivery to Non-Human Primates. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 29(3). 281–287. 16 indexed citations

15.

Shivakoti, Rupak, Debra Hauer, Robert J. Adams, et al.. (2014). Limited In Vivo Production of Type I or Type III Interferon After Infection of Macaques with Vaccine or Wild-Type Strains of Measles Virus. Journal of Interferon & Cytokine Research. 35(4). 292–301. 17 indexed citations

16.

Lemon, Ken, Rory D. de Vries, Annelies W. Mesman, et al.. (2011). Early Target Cells of Measles Virus after Aerosol Infection of Non-Human Primates. PLoS Pathogens. 7(1). e1001263–e1001263. 169 indexed citations

17.

Ludlow, Martin, W. Paul Duprex, S. Louise Cosby, Ingrid V. Allen, & Stephen McQuaid. (2007). Advantages of using recombinant measles viruses expressing a fluorescent reporter gene with vibratome slice technology in experimental measles neuropathogenesis. Neuropathology and Applied Neurobiology. 34(4). 424–434. 18 indexed citations

18.

Singethan, Katrin, et al.. (2006). CD9-dependent regulation of Canine distemper virus-induced cell–cell fusion segregates with the extracellular domain of the haemagglutinin. Journal of General Virology. 87(6). 1635–1642. 18 indexed citations

19.

O’Neill, H. J., Grace Ong, S Christie, et al.. (2003). Clinical assessment of a generic DNA amplification assay for the identification of respiratory adenovirus infections. Journal of Clinical Virology. 26(3). 331–338. 17 indexed citations

20.

Duprex, W. Paul, Stephen McQuaid, Lars Hangartner, Martin Billeter, & B. K. Rima. (1999). Observation of Measles Virus Cell-to-Cell Spread in Astrocytoma Cells by Using a Green Fluorescent Protein-Expressing Recombinant Virus. Journal of Virology. 73(11). 9568–9575. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact